Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

drug-drug conjugate NUV-1511

A drug-drug conjugate (DDC) composed of an as of yet undisclosed tumor-targeting agent conjugated to an as of yet undisclosed chemotherapeutic agent, with potential antineoplastic activity. Upon administration, DDC NUV-1511 targets and binds to the as of yet undisclosed receptor expressed in certain tumor types. The chemotherapeutic agent kills the cancer cells, through an as of yet unknown mechanism of action. DDCs may be able to increase efficacy while reducing systemic toxicity.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	DDC NUV-1511
Code name:	NUV 1511 NUV-1511 NUV1511

drug-drug conjugate NUV-1511

Search NCI's Drug Dictionary